Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
48,55 USD | -1,16% | +0,52% | -41,85% |
29/05 | CYTOKINETICS, INCORPORATED : Truist Securities ottimista sul caso | ZM |
28/05 | Cytokinetics chiude un'offerta di azioni da 500 milioni di dollari | MT |
Attività
Numero di dipendenti: 423
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Muscle Activators
100,0
%
| 95 | 100,0 % | 8 | 100,0 % | -92,04% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 95 | 100,0 % | 8 | 100,0 % | -92,04% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Robert Blum
CEO | Chief Executive Officer | 60 | 01/07/98 |
Kari Loeser
CMP | Compliance Officer | - | 01/11/21 |
Stuart Kupfer
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/20 |
Daniel Casper
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/17 |
Fady Malik
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/01/98 |
Eric Terhaerdt
COO | Chief Operating Officer | - | 01/01/19 |
Diane Weiser
IRC | Investor Relations Contact | - | 01/04/15 |
John Faurescu
LAW | General Counsel | - | - |
Yulymae Dinapoli
HRO | Human Resources Officer | - | 01/11/21 |
Jeff Lotz
SAM | Sales & Marketing | - | 01/09/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Nancy Wysenski
BRD | Director/Board Member | 66 | 20/11/20 |
Edward Kaye
BRD | Director/Board Member | 75 | 20/05/16 |
Santo Costa
BRD | Director/Board Member | 78 | 01/10/10 |
B. Parshall
BRD | Director/Board Member | 70 | 07/02/13 |
Wendell Wierenga
BRD | Director/Board Member | 76 | 09/02/11 |
John Henderson
CHM | Chairman | 79 | 01/02/09 |
Robert Blum
CEO | Chief Executive Officer | 60 | 01/07/98 |
Director/Board Member | 63 | 08/04/22 | |
Muna Bhanji
BRD | Director/Board Member | 61 | 17/02/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 114 577 882 | 113 953 355 ( 99,45 %) | 0 | 99,45 % |
Coordinate società
Cytokinetics, Inc.
350 Oyster Point Boulevard
94080, South San Francisco
+650 624 3000
http://www.cytokinetics.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-41,85% | 5,57 Mrd | |
+11,60% | 106 Mrd | |
-4,68% | 24,28 Mrd | |
-0,82% | 21,96 Mrd | |
-10,12% | 18,16 Mrd | |
-42,12% | 16,37 Mrd | |
-17,47% | 15,56 Mrd | |
+2,77% | 13,63 Mrd | |
+34,58% | 12,27 Mrd | |
+77,64% | 8,87 Mrd |
- Borsa valori
- Azioni
- Azione CYTK
- Società Cytokinetics, Incorporated